672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMID 18656619)

Published in Surgery on May 27, 2008

Authors

Nicholas C Wisnoski1, Courtney M Townsend, William H Nealon, Jean L Freeman, Taylor S Riall

Author Affiliations

1: Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555-0542, USA.

Articles citing this

Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. Oncologist (2011) 1.20

Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas. Mayo Clin Proc (2009) 1.04

Mixed acinar-endocrine carcinoma of pancreas: A case report and brief review of the literature. Onco Targets Ther (2015) 1.04

Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease. Cancer Invest (2010) 1.03

[What's new? The 2010 WHO classification for tumours of the pancreas]. Pathologe (2011) 0.99

Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review. Langenbecks Arch Surg (2010) 0.98

Mixed acinar-endocrine carcinoma of the pancreas with intraductal growth into the main pancreatic duct: Report of a case. Surg Today (2010) 0.95

Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas. Sci Rep (2015) 0.95

Pancreatic cancer. Br J Pharmacol (2014) 0.92

An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development. J Cancer (2011) 0.88

Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association. J Clin Endocrinol Metab (2011) 0.87

Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases. Virchows Arch (2014) 0.87

Acinar Cell Carcinoma of the Pancreas: A Literature Review and Update. Indian J Surg (2014) 0.86

Long-term survival after a repetitive surgical approach in a patient with acinar cell carcinoma of the pancreas and recurrent liver metastases: report of a case. Surg Today (2010) 0.86

Clinical features and CT/MRI findings of pancreatic acinar cell carcinoma. Int J Clin Exp Med (2015) 0.85

Precursor lesions of early onset pancreatic cancer. Virchows Arch (2011) 0.83

Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin. J Transl Med (2016) 0.82

Pancreatic panniculitis in a patient with pancreatic-type acinar cell carcinoma of the liver - case report and review of literature. BMC Cancer (2016) 0.82

Acinar cell carcinoma of the pancreas: clinical and cytomorphologic characteristics. Korean J Pathol (2013) 0.80

Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-containing Regimen. Cancer Res Treat (2016) 0.79

Comparison of pancreatic acinar cell carcinoma and adenocarcinoma using multidetector-row computed tomography. World J Gastroenterol (2013) 0.79

Prolonged Survival in a Patient with a Pancreatic Acinar Cell Carcinoma. Case Rep Oncol (2015) 0.79

Molecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non-neoplastic nature. Oncol Lett (2014) 0.78

Acinar cell carcinoma: a report of 19 cases with a brief review of the literature. World J Surg Oncol (2016) 0.78

Surgical and molecular pathology of pancreatic neoplasms. Diagn Pathol (2016) 0.77

Endoscopic ultrasound in the diagnosis of acinar cell carcinoma of the pancreas: contrast-enhanced endoscopic ultrasound, endoscopic ultrasound elastography, and pathological correlation. Endosc Int Open (2016) 0.76

The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer. Oncotarget (2016) 0.75

AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer. Korean J Hepatobiliary Pancreat Surg (2014) 0.75

Multimodal treatment of hepatic metastasis in the form of a bile duct tumor thrombus from pancreatic acinar cell carcinoma: case report of successful resection after chemoradiation therapy. Case Rep Gastroenterol (2012) 0.75

A comparison study of pancreatic acinar cell carcinoma with ductal adenocarcinoma using computed tomography in Chinese patients. Onco Targets Ther (2016) 0.75

Magnetic resonance imaging of less common pancreatic malignancies and pancreatic tumors with malignant potential. Eur J Radiol Open (2014) 0.75

A case of pancreatic acinar cell carcinoma metastatic to skin. Rare Tumors (2010) 0.75

Pancreatic acinar cell carcinoma with extensive tumor embolism at the trunk of portal vein and pancreatic intraductal infiltration. Clin J Gastroenterol (2017) 0.75

Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement: Two case reports and literature review. Medicine (Baltimore) (2017) 0.75

Treatment of a mixed acinar-endocrine carcinoma with uptake on (68)Gallium-DOTATOC positron emission tomography-computed tomography: A case report. Oncol Lett (2017) 0.75

Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma. J Cancer Res Clin Oncol (2016) 0.75

Articles by these authors

Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med (2005) 8.32

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg (2006) 7.18

One thousand consecutive pancreaticoduodenectomies. Ann Surg (2006) 6.59

Growth in the care of older patients by hospitalists in the United States. N Engl J Med (2009) 6.14

Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer (2005) 3.56

Association between cholecystectomy with vs without intraoperative cholangiography and risk of common duct injury. JAMA (2013) 3.52

Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst (2006) 3.10

Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med (2010) 3.09

Overuse of screening colonoscopy in the Medicare population. Arch Intern Med (2011) 3.08

Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst (2005) 2.93

An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res (2004) 2.75

Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. J Natl Cancer Inst (2007) 2.60

Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol (2004) 2.59

Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg (2004) 2.35

Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg (2007) 2.28

Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association. J Am Coll Surg (2009) 2.18

Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol (2005) 2.10

Effect of nurse case management on the treatment of older women with breast cancer. J Am Geriatr Soc (2003) 1.92

Continuity of outpatient and inpatient care by primary care physicians for hospitalized older adults. JAMA (2009) 1.90

Evidence-based current surgical practice: calculous gallbladder disease. J Gastrointest Surg (2012) 1.88

Characteristics of urologists predict the use of androgen deprivation therapy for prostate cancer. J Clin Oncol (2007) 1.79

Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med (2008) 1.76

Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg (2006) 1.73

Ethnic differences in in-hospital place of death among older adults in California: effects of individual and contextual characteristics and medical resource supply. Med Care (2009) 1.73

Outcomes following pancreatic resection: variability among high-volume providers. Surgery (2008) 1.73

Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg (2006) 1.67

Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg (2009) 1.66

Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg (2006) 1.65

Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Med Care (2004) 1.62

Predictors of colorectal cancer following a negative colonoscopy in the Medicare population. Dig Dis Sci (2011) 1.62

The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit (2005) 1.60

Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms. Health Serv Res (2002) 1.58

A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med (2002) 1.49

Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg (2004) 1.49

Overuse of CT in patients with complicated gallstone disease. J Am Coll Surg (2011) 1.48

Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer. J Clin Oncol (2010) 1.48

The effect of age on short-term outcomes after pancreatic resection: a population-based study. Ann Surg (2008) 1.46

Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med (2002) 1.42

Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg (2006) 1.41

Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv (2008) 1.39

Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med (2006) 1.38

Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg (2006) 1.36

Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist (2006) 1.35

Trends and disparities in regionalization of pancreatic resection. J Gastrointest Surg (2007) 1.35

The influence of marital status on stage at diagnosis and survival of older persons with melanoma. J Gerontol A Biol Sci Med Sci (2007) 1.33

Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys (2007) 1.31

Variation in false-positive rates of mammography reading among 1067 radiologists: a population-based assessment. Breast Cancer Res Treat (2006) 1.30

VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis. Int J Cancer (2011) 1.27

Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res (2003) 1.27

Failure to perform cholecystectomy for acute cholecystitis in elderly patients is associated with increased morbidity, mortality, and cost. J Am Coll Surg (2010) 1.27

Comorbid disease and cancer: the need for more relevant conceptual models in health services research. J Clin Oncol (2005) 1.26

Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med (2013) 1.22

Sterile fluid collections in acute pancreatitis: catheter drainage versus simple aspiration. Cardiovasc Intervent Radiol (2006) 1.19

Video-assisted thoracic surgery removal of foreign bodies after penetrating chest trauma. J Am Coll Surg (2006) 1.17

Hospice use by Hispanic and non-Hispanic white cancer decedents. Health Serv Res (2004) 1.13

Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J Am Coll Surg (2007) 1.12

Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. J Biol Chem (2002) 1.11

Socioeconomic status and survival in older patients with melanoma. J Am Geriatr Soc (2006) 1.11

Cyclic adenosine 5'-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways. Mol Endocrinol (2006) 1.10

Bringing the patient back in. Guidelines, practice variations, and the social context of medical practice. Int J Technol Assess Health Care (2002) 1.09

Gallstone pancreatitis in older patients: Are we operating enough? Surgery (2011) 1.06

The role of protein kinase D in neurotensin secretion mediated by protein kinase C-alpha/-delta and Rho/Rho kinase. J Biol Chem (2004) 1.04

Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues. Endocr Rev (2003) 1.04

Preoperative laboratory testing in patients undergoing elective, low-risk ambulatory surgery. Ann Surg (2012) 1.03

Factors associated with delayed gastric emptying after pancreaticoduodenectomy. HPB (Oxford) (2013) 1.02

415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res (2011) 1.01

PKD1, PKD2, and their substrate Kidins220 regulate neurotensin secretion in the BON human endocrine cell line. J Biol Chem (2007) 1.01

Mammography use among older women of seven Latin American and Caribbean cities. Prev Med (2006) 1.01

Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors. Carcinogenesis (2013) 1.01

Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors. Clin Cancer Res (2014) 0.99

Pancreatic neoplasms in pregnancy: diagnosis, complications, and management. J Gastrointest Surg (2011) 0.99

Implementation of a critical pathway for complicated gallstone disease: translation of population-based data into clinical practice. J Am Coll Surg (2011) 0.99

Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg (2007) 0.99

Pap smear use in a population of older Mexican-American women. Women Health (2002) 0.99

Variation in the use of intraoperative cholangiography during cholecystectomy. J Am Coll Surg (2012) 0.98

Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway. J Biol Chem (2004) 0.98

Survival of women after breast conserving surgery for early stage breast cancer. Breast Cancer Res Treat (2002) 0.97

The role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in distinguishing pancreatic cystic lesions. Diagn Cytopathol (2007) 0.97

PREOP-Gallstones: A Prognostic Nomogram for the Management of Symptomatic Cholelithiasis in Older Patients. Ann Surg (2015) 0.97

Underutilization of surgical resection in patients with localized pancreatic cancer. Ann Surg (2007) 0.97

Development and characterization of a novel in vivo model of carcinoid syndrome. Clin Cancer Res (2009) 0.96

Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res (2011) 0.96

mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. Am J Physiol Cell Physiol (2011) 0.96